Ernexa Therapeutics Inc.
USD6.64
-0.39 (-5.48%)
CEO
Sanjeev Luther
IPO Date
1991-08-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.67
Prev. Close
$7.03
Day Low
$6.50
Day High
$7.10
52W Low
$3.18
52W High
$71.50
Market Cap
$0.00B
Volume
0.00M
| -2.8 |
| 31 Dec 2023 | FY | -247.1% | -31864.7% | -970.4% | -44.1% | 18.74 | 1.46 | -6.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -203.0% | -110.3% | 0.34 | 1.79 | -6.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -480.5% | -388.7% | 0.11 | 5.10 | -22.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 155.5% | 92.3% | 0.38 | 0.55 | 195.6 |
| 31 Dec 2019 | FY | 60.4% | -10.3% | -40.2% | -13.4% | 1.19 | 1.00 | -46.3 |
| 31 Dec 2018 | FY | 64.1% | -1.1% | -3.7% | -1.7% | 0.55 | 1.69 | -303.6 |
| 31 Dec 2017 | FY | 66.7% | -5.1% | -19.5% | -6.5% | 0.98 | 0.90 | -143.2 |
| 31 Dec 2016 | FY | 63.6% | -13.1% | -71.9% | -17.1% | 2.10 | 1.60 | -83.0 |
| -1.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -34.7% | -20.1% | 0.15 | 1.58 | -1.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -70.6% | -41.4% | 0.13 | 1.81 | -0.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 137.8% | -162.1% | -0.48 | 0.21 | -4.3 |
| 31 Dec 2024 | Q4 | 100.0% | -575900.0% | -338.6% | -109.3% | 0.40 | 0.80 | -9.8 |
| 30 Sept 2024 | Q3 | 112.3% | -5462.8% | 58.6% | -344.7% | -0.74 | 0.48 | -0.8 |
| 30 Jun 2024 | Q2 | -102.1% | -11763.8% | 64.8% | -11.9% | -5.77 | 0.37 | -6.9 |
| 31 Mar 2024 | Q1 | -1180.9% | -14142.6% | 194.8% | -13.4% | -13.91 | 0.79 | -7.0 |
| 31 Dec 2023 | Q4 | -288.2% | -36194.1% | -275.5% | -12.5% | 18.74 | 1.46 | -5.9 |